Feed ALIVUS.BO
AL

Alivus Life Sciences Limited

ALIVUS.BO · BSE

₹1,375.00 -0.61% (-₹8.40)
1M -0.24%
Market Cap ₹169.7B
P/E Ratio 30.57x
Div. Yield 0.36%
ROE 18.17%

Bulios Fair Price

₹957.07

30.4% downside

Current Price

₹1,375

Undervalued Fair Value Overvalued

According to Bulios Fair Price, ALIVUS.BO is currently overvalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Weak
3/9
Valuation
22 /100
Expensive
EV/EBITDA 20.82x
P/S 6.85x
P/B 5.09x
Growth
45 /100
Stable
Rev. growth 7.05%
FCF growth 3.85%
Book val. growth 45.79%
Profitability
71 /100
Strong
Net margin 22.40%
Op. margin 32.10%
FCF margin 0.00%
Quality
84 /100
Excellent
ROE 18.17%
ROA N/A
Asset turnover N/A
Debt
100 /100
Low
Int. coverage 217.75x
Net debt/EBITDA 0.00x
Debt/Equity 0.00x
Stability
72 /100
Stable
Rev. volatility 4.49%
EPS volatility 4.43%
Profitable years 4

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about ALIVUS.BO
Online

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Yasir Yusufali Rawjee

Employees

2,272

Headquarters

Mumbai

Upcoming events

05 NOV

Earnings

Upcoming earnings report

29d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.